Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific

Launched by CHINESE UNIVERSITY OF HONG KONG · Oct 12, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how well a treatment called endovascular thrombectomy (EVT) works for patients with a specific type of stroke known as large vessel occlusion (LVO) ischemic stroke in real-life situations. EVT is a procedure that can help remove blood clots from the brain, leading to better recovery and survival for patients who have suffered a stroke. Researchers want to understand how various factors, such as healthcare policies and treatment techniques, affect the success of EVT in everyday practice across the Asia-Pacific region.

To participate in this trial, you need to be over 18 years old and have been diagnosed with an ischemic stroke that is suspected to involve a large blood vessel blockage. If you qualify, you will be part of a study that looks at how well this treatment works in real-world scenarios, not just in controlled clinical trials. This is important because it helps bridge the gap between research findings and everyday patient care. If you are considering joining, you'll be contributing to valuable insights that could improve stroke treatment for many patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient who are over 18 years of age.
• • Patient with ischemic stroke with suspected large vessel occlusion (LVO), defined as occlusion of the internal carotid artery (ICA), M1 or M2 segment of the middle cerebral artery (MCA), or basilar artery (BA).
• Exclusion Criteria:
• • Patient with isolated vertebral artery occlusion not involving the BA.